Condition: Atrial Fibrillation New Onset · Acute Myocardial Infarction · Sponsor: Shanghai 10th People's Hospital
To validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively designed hospital-based registry. To characterize those factors that contribute to the progression of post-MI NOAF burden. To establish a prediction model for the risk stratification of patients with NOAF complicating AMI. To explore the clinical usefulness of NOAF burden in guiding the anticoagulation therapy among patients with post-MI NOAF.
This description comes directly from the study's public registry record.
Jiachen Luo, M.D., Ph.D. · +86-188-0179-0469 · messichen@tongji.edu.cn
Always discuss trial participation with your own doctor first.
| Kaifeng Central Hospital | Kaifeng, Henan, China | Recruiting |
| Luoyang Central Hospital | Luoyang, Henan, China | Recruiting |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou, Henan, China | Recruiting |
| Department of Cardiology, Shanghai Tenth People's Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| Shanghai Seventh People's Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04528511